Canceromics: Cancer Genomics and Proteomics

Using Functional Genomics and Proteomics approaches to elucidate genes and proteins with differential expression in cancer cells. Identification of new markers with prognostic or diagnostic value in clinic.

Collaborating Groups

Dr. Ralph J. DeBerardinis (Children’s Medical Center Research Institute, University of Texas–Southwestern Medical Center, Dallas, TX, USA). Collaboration on cancer metabolic reprogramming in human glioma cell lines with targeted GA expression.

Dr. Mariia Yuneva (MRC, National Institute for Medical Research, London, UK)

Dr. Jan Albrecht (Dept. of Neurotoxicology, Polish Academy of Sciences, Warsaw, Poland)